Sort
85,873 grants matching “alzheimers”
Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD Biomarker
$8,033,304Suzanne Craft · Wake Forest University Health Sciences · RF1 · FY2012 · AG
ASPirin in Reducing Events in the Elderly - eXTension
$8,032,026Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2023 · AG
Creation of an Institutional Biobanking Facility
$8,000,000Muredach P Reilly · Columbia University Health Sciences · C06 · FY2020 · OD
Alzheimer's Disease Neuroimaging Initiative
$8,000,000Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2016 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,000,000Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2010 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,000,000Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2014 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,000,000Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2018 · AG
A National, Theranostic Cyclotron Resource to Drive Fundamental and Translational Medical Science
$8,000,000Robert N Golden · University Of Wisconsin-Madison · C06 · FY2023 · OD
Stillman Chronic Disease Research and Training Shared Facility
$7,999,408Rosianna R Gray · Stillman College · C06 · FY2023 · OD
Bridge Funding for Dominantly Inherited Alzheimer Network
$7,994,551Randall J Bateman · Washington University · U19 · FY2025 · AG
A Washington University Gnotobiotic Research, Education and Transgenic (WU-GREaT) center for modeling genetic and environmental effectors of disease pathogenesis
$7,972,413Mark E. Lowe · Washington University · C06 · FY2019 · OD
ASPirin in Reducing Events in the Elderly - eXTension
$7,969,915Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2022 · AG
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)
$7,950,817Margaret A Pericak-Vance · University Of Miami School Of Medicine · U19 · FY2023 · AG
THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials
$7,948,867Martin J. Sliwinski · Pennsylvania State University, The · U24 · FY2025 · AG
HABS-HD - Core D - Omics Core
$7,902,235Leigh A Johnson · University Of North Texas Hlth Sci Ctr · U19 · FY2025 · AG
Clinical Core
$7,862,590Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2019 · AG
National Alzheimer's Coordinating Center
$7,845,994Walter A Kukull · University Of Washington · U24 · FY2022 · AG
Alzheimer's Disease Neuroimaging Initiative
$7,812,000Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2006 · AG
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
$7,811,344Xue Hua · Athira Pharma, Inc. · R01 · FY2020 · AG
Engagement Core
$7,807,886Monica G Rivera-Mindt · Northern California Institute/Res/Edu · U19 · FY2022 · AG
Longitudinal multicenter head-to-head harmonization of tau PET tracers
$7,801,112Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Alzheimer's Disease Cooperative Study
$7,799,987Howard Feldman · University Of California, San Diego · U19 · FY2017 · AG
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)
$7,791,576Margaret A Pericak-Vance · University Of Miami School Of Medicine · U19 · FY2022 · AG
Clinical and Translational Science Collaborative of Cleveland
$7,746,299Michael W. Konstan · Case Western Reserve University · UL1 · FY2019 · TR
Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study
$7,733,126Cecilia Sungmin Lee · University Of Washington · R01 · FY2024 · AG